Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05429515
PHASE4

Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury

Sponsor: Peking Union Medical College Hospital

View on ClinicalTrials.gov

Summary

In patients with multiple myeloma-related acute kidney injury, compare the renal outcome of chemotherapy combined with HFR-SUPRA to chemotherapy combined with hemodialysis.

Official title: Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury: a Prospective Cohort Study

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2022-07-01

Completion Date

2032-12-01

Last Updated

2022-06-23

Healthy Volunteers

No

Interventions

PROCEDURE

HFR-SUPRA

HFR-SUPRA everyday for 3 days, then 3 times/week until patients do not require dialysis.

PROCEDURE

hemodialysis

hemodialysis everyday for 3 days, then 3 times/week until patients do not require dialysis.

DRUG

Chemotherapy

chemotherapy protocol will be made by hematologists.